Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA2881 AG-825Summary: AG-825 is a selective, ATP-competitive, inhibitor of tyrosine phosphorylation. -
BA2883 S130Summary: S130 is a high affinity, selective inhibitor of cysteine proteases with a value of 3.24 μM. -
BA2884 TegaserodSummary: Tegaserod is an orally effective 5-hydroxytryptamine receptor 4(;) agonist and receptor antagonist. -
BA2885 ROC-325Summary: ROC-325 is a potent orally active autophagy inhibitor with strong anticancer activity. -
BA2886 MBM-55Summary: MBM-55 is an effective inhibitor. -
BA2887 TironSummary: A non-toxic chelator of multiple metals -
BA2888 UlinastatinSummary: Ulinastatin (Uristatin) is a trypsin and serine protease inhibitor. -
BA2890 INI-43Summary: INI-43 is an inhibitor that interferes with the nuclear localization of Kpnβ1 and known Kpnβ1cargo proteins, NFAT, NFκB, AP-1 and NFY. -
BA2891 ArtemisiteneSummary: Artemisitene is a natural derivative of Artemisinin, an activator with antioxidant and anticancer activity. -
BA2892 FOXO4-DRISummary: FOXO4-DRI is a cell-permeable peptide antagonist.


